NEW YORK, NY / ACCESSWIRE / December 13, 2021 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Talis Biomedical Corporation ("Talis" or the "Company") ...
MENLO PARK, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (NASDAQ: TLIS) today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use ...
NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Talis Biomedical Corporation (NASDAQ: TLIS) on ...
The point-of-care testmaker Talis Biomedical is undergoing a second wave of layoffs this year after struggling to get its COVID-19 diagnostic off the ground. Alongside its second-quarter earnings ...
Talis Biomedical (NASDAQ:TLIS) stock shot up 35% in morning trading Tuesday on news that the company was seeking strategic alternatives and cutting 90% of its workforce to save cash. The diagnostics ...